Among cancer patients experiencing pulmonary embolism, those with pancreatic cancer, hematological malignancies, lung cancer, gastric cancer, and brain cancer are at the highest risk for VTE recurrence, requiring prolonged anticoagulation, preferably using LMWH or direct oral anticoagulants over vitamin K antagonists.